Exclusive US distributor Phase Scientific will now roll out the rapid test via an established commercial footprint and other distribution agreements.
Clinical labs are exploring new business opportunities as consumers take more control of their healthcare and bypass their ...
The approval marks the eighth FDA-approved CDx indication for the company's PD-L1 IHC 22C3 pharmDx, Code SK006, test for use with Keytruda.
NEW YORK – Laboratory Corporation of America said in a filing with the US Securities and Exchange Commission on Friday that it has entered into an agreement for a term loan of $750 million. The ...
With the license, MeMed can offer its BV test, which is intended to distinguish between bacterial and viral infections, in Canada.
NEW YORK – MicrosenseDx, a Cambridge, UK-based diagnostics developer, has inked a strategic partnership with France's ProteoGenix to speed up development of a rapid diagnostic test for sepsis.
Last week, readers were most interested in a story about Pluslife's MiniDock MTB, the only test in WHO's new class designation for tuberculosis diagnostic tests.
An initial $1.35 million has been deployed to the University of California, San Francisco, to initiate the program, with additional funding announcements forthcoming.
Intelligenome will contribute its testing platform to an NIH-funded program centered on cell-free DNA tuberculosis detection from respiratory and blood samples.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results